Filing Details

Accession Number:
0001209191-21-058002
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-28 19:46:45
Reporting Period:
2021-09-23
Accepted Time:
2021-09-28 19:46:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590750 Viridian Therapeutics Inc. VRDN Services-Medical Laboratories (8071) 471187261
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1863769 Frazier Life Sciences Public Fund, L.p. C/O Frazier Healthcare Partners
601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1879465 Fhmlsp, L.l.c. C/O Frazier Healthcare Partners
601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1879466 Fhmlsp, L.p. C/O Frazier Healthcare Partners
601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-23 200,000 $11.00 1,505,200 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares are held directly by Frazier Life Sciences Public Fund L.P. The general partner of Frazier Life Sciences Public Fund L.P. is FHMLSP, L.P. and the general partner of FHMLSP, L.P. is FHMLSP, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Frazier Life Sciences Public Fund L.P. FHMLSP, L.P. and FHMLSP, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by Frazier Life Sciences Public Fund L.P., except to the extent of its pecuniary interest therein, if any.